Terms: = Skin cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4
54 results:
1. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway.
Wang Y; Zhang A; Li Q; Liu C
J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
[TBL] [Abstract] [Full Text] [Related]
2. TIF1γ and smad4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
[TBL] [Abstract] [Full Text] [Related]
3. Methylation status, mRNA and protein expression of the smad4 gene in patients with non-melanocytic skin cancers.
Gürsel Ürün Y; Budak M; Usturalı Keskin E
Mol Biol Rep; 2023 Sep; 50(9):7295-7304. PubMed ID: 37428273
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Utility of Bland Embolization Using Microspheres for Painful Malignant Musculoskeletal Tumors.
Taniguchi J; Takaki H; Kodama H; Kawaguchi T; Takahagi M; Ogasawara A; Kako Y; Kobayashi K; Minami T; Futani H; Yamakado K
In Vivo; 2023; 37(4):1816-1821. PubMed ID: 37369519
[TBL] [Abstract] [Full Text] [Related]
5. SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation.
Yi X; Wang H; Yang Y; Wang H; Zhang H; Guo S; Chen J; Du J; Tian Y; Ma J; Zhang B; Wu L; Shi Q; Gao T; Guo W; Li C
Signal Transduct Target Ther; 2023 Mar; 8(1):107. PubMed ID: 36918544
[TBL] [Abstract] [Full Text] [Related]
6. Characterization of TGF-β signaling in a human organotypic skin model reveals that loss of TGF-βRII induces invasive tissue growth.
Ye Z; Kilic G; Dabelsteen S; Marinova IN; Thøfner JFB; Song M; Rudjord-Levann AM; Bagdonaite I; Vakhrushev SY; Brakebusch CH; Olsen JV; Wandall HH
Sci Signal; 2022 Nov; 15(761):eabo2206. PubMed ID: 36413597
[TBL] [Abstract] [Full Text] [Related]
7. An additional patient with smad4-Juvenile Polyposis-Hereditary hemorrhagic telangiectasia and connective tissue abnormalities: smad4 loss-of-function and gain-of-function pathogenic variants result in contrasting phenotypes.
Gheewalla GM; Luther J; Das S; Kreher JB; Scimone ER; Wong AW; Lindsay ME; Lin AE
Am J Med Genet A; 2022 Oct; 188(10):3084-3088. PubMed ID: 35869926
[TBL] [Abstract] [Full Text] [Related]
8. Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma.
Zhao X; Yue D; Qian J; Zhang L; Song J; Zhang B; Zhang C; Sun L; Ma Y; Zhang H; Wang C
Front Immunol; 2022; 13():794217. PubMed ID: 35173719
[TBL] [Abstract] [Full Text] [Related]
9. A Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression.
Anderson WJ; Tsai HK; Sholl LM; Hirsch MS
Int J Surg Pathol; 2022 Sep; 30(6):606-615. PubMed ID: 35048731
[No Abstract] [Full Text] [Related]
10. Overexpression of microRNA-130a represses uveal melanoma cell migration and invasion through inactivation of the Wnt/β-catenin signaling pathway by downregulating USP6.
Wu S; Han M; Zhang C
Cancer Gene Ther; 2022 Jul; 29(7):930-939. PubMed ID: 34522027
[TBL] [Abstract] [Full Text] [Related]
11. Eight novel susceptibility loci and putative causal variants in atopic dermatitis.
Tanaka N; Koido M; Suzuki A; Otomo N; Suetsugu H; Kochi Y; Tomizuka K; Momozawa Y; Kamatani Y; ; Ikegawa S; Yamamoto K; Terao C
J Allergy Clin Immunol; 2021 Nov; 148(5):1293-1306. PubMed ID: 34116867
[TBL] [Abstract] [Full Text] [Related]
12. TGFβ Signaling in Photoaging and UV-Induced skin cancer.
Ke Y; Wang XJ
J Invest Dermatol; 2021 Apr; 141(4S):1104-1110. PubMed ID: 33358021
[TBL] [Abstract] [Full Text] [Related]
13. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
[TBL] [Abstract] [Full Text] [Related]
14. Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma.
Todisco A; Internò V; Stucci LS; Ostuni C; Lovero D; D'Oronzo S; Mele F; Duda L; Palmirotta R; Silvestris F
Int J Biol Markers; 2019 Dec; 34(4):421-426. PubMed ID: 31556336
[TBL] [Abstract] [Full Text] [Related]
15. SMAD signaling promotes melanoma metastasis independently of phenotype switching.
Tuncer E; Calçada RR; Zingg D; Varum S; Cheng P; Freiberger SN; Deng CX; Kleiter I; Levesque MP; Dummer R; Sommer L
J Clin Invest; 2019 Apr; 129(7):2702-2716. PubMed ID: 31039140
[TBL] [Abstract] [Full Text] [Related]
16. Predictive genetic profiles for regional lymph node metastasis in primary cutaneous melanoma: a case-matched pilot study.
Nye A; Collins JD; Porter CL; Montes de Oca M; George K; Stafford CG; Schammel CMG; Horton S; Trocha SD
Melanoma Res; 2018 Dec; 28(6):555-561. PubMed ID: 30179987
[TBL] [Abstract] [Full Text] [Related]
17. Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma.
Wu F; Weigel KJ; Zhou H; Wang XJ
Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):98-105. PubMed ID: 29206939
[TBL] [Abstract] [Full Text] [Related]
18. Basal Cell Carcinoma With Matrical Differentiation: Clinicopathologic, Immunohistochemical, and Molecular Biological Study of 22 Cases.
Kyrpychova L; Carr RA; Martinek P; Vanecek T; Perret R; Chottová-Dvořáková M; Zamecnik M; Hadravsky L; Michal M; Kazakov DV
Am J Surg Pathol; 2017 Jun; 41(6):738-749. PubMed ID: 28368926
[TBL] [Abstract] [Full Text] [Related]
19. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.
Mishra AK; Kadoishi T; Wang X; Driver E; Chen Z; Wang XJ; Wang JH
Oncotarget; 2016 Dec; 7(49):81341-81356. PubMed ID: 27835902
[TBL] [Abstract] [Full Text] [Related]
20. Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells.
Spender LC; Ferguson GJ; Liu S; Cui C; Girotti MR; Sibbet G; Higgs EB; Shuttleworth MK; Hamilton T; Lorigan P; Weller M; Vincent DF; Sansom OJ; Frame M; Dijke PT; Marais R; Inman GJ
Oncotarget; 2016 Dec; 7(50):81995-82012. PubMed ID: 27835901
[TBL] [Abstract] [Full Text] [Related]
[Next]
